A0873750
N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-serine , ≥98% , 120173-57-1
Synonym(s):
N-α-Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D -galactopyranosyl)-L -serine;Fmoc-Ser(Ac3AcNH-α-Gal)-OH;N-α-Fmoc-O-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-serine
CAS NO.：120173-57-1
Empirical Formula: C32H36N2O13
Molecular Weight: 656.63
MDL number: MFCD00171375
| Pack Size | Price | Stock | Quantity |
| 5mg | RMB188.00 | In Stock |
|
| 25mg | RMB676.00 | In Stock |
|
| 100mg | RMB3999.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 856.8±65.0 °C(Predicted) |
| Density | 1.39±0.1 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | DMF: 16 mg/mL; DMSO: 14 mg/mL; Ethanol: 14 mg/mL; PBS (pH 7.2): 0.3 mg/mL |
| form | A solid |
| pka | 3.34±0.10(Predicted) |
| color | White to off-white |
| InChIKey | ORICVOOXZDVFIP-VOZJJELXSA-N |
Description and Uses
Fluorescently labeled glycopeptides containing GalNAcα1-O-Ser/Thr residues provide valuable immunology probes for the development of cancer vaccines.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H351 |
| Precautionary statements | P201-P202-P281-P308+P313-P405-P501-P264-P270-P301+P312-P330-P501 |
| WGK Germany | 3 |
| HS Code | 2932 99 00 |
RELATED PRODUCTS
N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine
FMOC-L-THR(ALPHA-D-MANAC4)-OH
169219-08-3
169219-08-3
Fmoc-L-Thr(β-D-Glc(Ac)4)-OH
130548-92-4
130548-92-4
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2R,3R,4S,5S,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)propanoicacid
96383-44-7
96383-44-7
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH
160067-63-0
160067-63-0